Platelet BioGenesis, Inc. — Form D
Platelet BioGenesis, Inc. of Watertown, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-05-31. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-05-31
- Form: D
- Accession: 0001679766-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Minimum investment: $10K
- Investors: 32
- Date of first sale: 2017-05-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-287745
Issuer
- Name: Platelet BioGenesis, Inc.
- CIK: 0001679766
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 65 Grove Street, Suite 303, Watertown, MA, 02472
- Phone: 857-299-6024
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Peter Finn | Executive Officer | Watertown, MA |
| Philip Reilly | Director | Hingham, MA |
| Mark McDade | Director | South San Francisco, CA |
| Richard Murray | Director | South San Francisco, CA |
| Steven Altschuler | Director | WATERTOWN, MA |
| Steve Altschuler | Director | Watertown, MA |
| Jonathan Thon | Director | Malden, MA |
| Jonathan Thon | Executive Officer | Malden, MA |
| Sam Rasty | Director | Watertown, MA |
| Sam Rasty | Executive Officer | Watertown, MA |
| Chidozie Ugwumba | Director | Watertown, MA |
| Joseph Italiano | Director | Watertown, MA |
| Sven Karlsson | Director | CAMBRIDGE, MA |
| Sven Karlsson | Executive Officer | CAMBRIDGE, MA |
| Jonathan Erik Thon | Director | Dorchester, MA |
| Sven Erik Karlsson | Executive Officer | Boston, MA |
| Peter Erik Finn | Executive Officer | Needham, MA |
Other filings by this issuer (4)
More